Clinical Study to assess the tolerability and effectiveness of Haridradya Taila in Acne and Acne-induced Post-inflammatory Hyperpigmentation
DOI:
https://doi.org/10.55718/kja.199Keywords:
Acne, haridradya taila, pigmentation, ayurvedaAbstract
Acne is a condition of the pilosebaceous glands of skin characterized by anomalies in the production of sebum which includes both non-inflammatory lesions such as comedones (open and closed) and inflammatory lesions like pustules, papules and nodules. Patients with acne frequently seek treatment in inflammatory lesions state. Haridradya Taila is a classical preparation mentioned in kshudra rogadhikar of Chakradatta. The present study aimed to evaluate the safety and efficacy of haridradya taila in acne and acne induced post inflammatory hyperpigmentation. Total fifty patients in the age group of 18–45 years having mild to moderate acne and acne induced post inflammatory hyperpigmentation were enrolled. The statistical significance of the data was examined using SPSS. Clinical trial results were statistically significant for acne and acne induced post inflammatory hyperpigmentation. The results of this study suggest Haridradya Taila is safe and effective in the treatment of mild to moderate acne and acne induced post inflammatory hyperpigmentation.
References
Rocha MA, Costa CS, Bagatin E. Acne vulgaris: an inflammatory disease even before the onset of clinical lesions. Inflamm Allergy Drug Targets. 2014;13(3):162-7. doi: 10.2174/1871528113666140606110024. PMID: 24909146.
Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment Guidance for Industry; available at https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm May 2018.
Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012 Jan 28; 379(9813):361-72. doi: 10.1016/S0140-6736(11)60321-8. Epub 2011 Aug 29. Erratum in: Lancet. 2012 Jan 28; 379(9813):314. PMID: 21880356.
Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17:184–195. doi: 10.1111/j.1396-0296.2004.04019.x. PMID: 15113286.
Callender VD, St Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol. 2011 Apr 1;12(2):87–99. Doi:10.2165/11536930-000000000-00000. PMID: 21348540
Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009;28:77–85. Doi: 10.1016/j.sder.2009.04.001.PMID: 19608057
Chakradutta of Shri Chakrapanidatta, Prof. Ramanath Dwivedy(editor), Kshudra rogadhikar, 55 , Chaukhambha Sanskrit Bhawan, Varanasi-221001; p 316.
Bowe WP, Doyle AK, Crerand CE, Margolis DJ, Shalita AR. Body image disturbance in patients with acne vulgaris. J Clin Aesthet Dermatol. 2011 Jul;(7):35-41. PMID: 21779418; PMCID: PMC3140907.
Callender VD, Young CM, Kindred C, Taylor SC. Efficacy and Safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel for the Treatment of Acne and Acne-induced Post-inflammatory Hyperpigmentation in Patients with Skin of Color. J Clin Aesthet Dermatol. 2012 Jul;5(7):25-32. PMID:22798973; PMCID: PMC3396458.
Leyden J, Wortzman M, Baldwin EK.Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel. J Drugs Dermatol.2009 Apr;(4):383-8. PMID: 19363857.
Susruta Samhita of Maharsi Susruta, by Kaviraja Ambikadutta Shastri, edited with Ayurveda tattva sandipika, hindi commentary, nidansthana 13, Chaukhambha Sanskrit sansthan, Varanasi, 2016, p.372.
A textbook of Dravyguna Vijnana, Dr. Prakash L. Hegde, Dr. Harini A, revised edition vol 2, Chaukhambha publications, 2020, p.274, 282, 420, 475, 756.
A textbook of Dravyguna Vijnana, Dr. Prakash L. Hegde, Dr. Harini A, revised edition vol 3, Chaukhambha publications, 2021, p.267, 457, 523, 691.
